Showing results (781-790 of 3,769) with videos related to

Sort By:
Pageof 377
Radiation Oncology (London, England)|May 17, 2018
Evaluation of target dose inhomogeneity in breast cancer treatment due to tissue elemental differencesA Fogliata, F De Rose, A Stravato, et al.
Radiation Oncology (London, England)|May 3, 2018
Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology referenceConstantinos Zamboglou, Benedikt Thomann, Khodor Koubar, et al.
Radiation Oncology (London, England)|May 6, 2018
Identifying risk factors for L'Hermitte's sign after IMRT for head and neck cancerHannah M Laidley, David J Noble, Gill C Barnett, et al.
Radiation Oncology (London, England)|April 17, 2019
Development and characterisation of acquired radioresistant breast cancer cell linesMark Gray, Arran K Turnbull, Carol Ward, et al.
Radiation Oncology (London, England)|April 18, 2019
DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknifeRosa Morabito, Concetta Alafaci, Stefano Pergolizzi, et al.
Radiation Oncology (London, England)|August 22, 2018
A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)Carole Mercier, Piet Dirix, Paul Meijnders, et al.
Radiation Oncology (London, England)|August 26, 2018
Validation of new transmission detector transmission factors for online dosimetry: an experimental studySo-Yeon Park, Jong Min Park, Jung-In Kim, et al.
Radiation Oncology (London, England)|October 16, 2012
Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancerGregory Hess, Arie Barlev, Karen Chung, et al.
Radiation Oncology (London, England)|June 23, 2012
A comparison of radiographic techniques and electromagnetic transponders for localization of the prostateRyan D Foster, David A Pistenmaa, Timothy D Solberg
Radiation Oncology (London, England)|June 23, 2012
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningiomaMichael C Kreissl, Heribert Hänscheid, Mario Löhr, et al.
Pageof 377